Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022

1 Apr 2025

Abstract excerpt

In Switzerland, thirteen-valent pneumococcal conjugate vaccine (PCV13) has been introduced in 2011. During the COVID-19 pandemic, cases of invasive pneumococcal disease (IPD) have decreased but consequences on the serotype epidemiology are less clear. The objective of the study has been to analyse the impact of PCV13 introduction and the COVID-19 pandemic on the IPD epidemiology and investigate the changes in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pneumocystis jirovecii pneumonia detection and treatment
Share to Pneumonia and Respiratory Infections
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40167153
DOI: 10.1080/22221751.2025.2488189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022PMID 40167153Read ↗

Nationwide Surveillance of Invasive Pneumococcal Disease in Spain: Impact of Conjugate Vaccines and the COVID-19 Pandemic (2009-2023)Semantic proximity Read ↗

Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceSemantic proximity Read ↗

Changes in pneumococcal deaths in the United States following the COVID-19 pandemicSemantic proximity Read ↗

Incidence rates, emerging serotypes and genotypes, and antimicrobial susceptibility of pneumococcal disease in Taiwan: A multi-center clinical microbiological study after PCV13 implementation.Semantic proximity Read ↗

Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study.Semantic proximity Read ↗

Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, BelgiumSemantic proximity Read ↗

Epidemiology of invasive pneumococcal disease in western Sweden during the first 11 years after the introduction of general childhood pneumococcal vaccinationSemantic proximity Read ↗

Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)Semantic proximity Read ↗

Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.Semantic proximity Read ↗

Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain.Semantic proximity Read ↗

Increasing incidence of serotype 38 invasive pneumococcal disease driven by the ST393 clone among children, Denmark 2022–2024Semantic proximity Read ↗

Population structure, serotype distribution and antibiotic resistance of Streptococcus pneumoniae causing invasive disease in Victoria, AustraliaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.